Elias P, Damle A, Casale M, Branson K, Churi C, Komatireddy R, Feramisco J A Web-Based Tool for Patient Triage in Emergency Department Settings: Validation Using the Emergency Severity Index. JMIR Med Inform. 2015 Jun 10;3(2):e23. doi: 10.2196/medinform.3508. Erratum In: JMIR Med Inform. 2015 Jun 15;3(3):e24.
Julian-Jimenez A, Palomo de los Reyes MJ, Lain Teres N [Coment on the original article: modelo predictor de ingreso hospitalario a la llegada al servicio de Urgencias]. An Sist Sanit Navar. 2012 Sep-Dec;35(3):493-6; author reply 497-9. doi: 10.23938/ASSN.0113. No abstract available. Spanish.
Kuriyama A, Urushidani S, Nakayama T Five-level emergency triage systems: variation in assessment of validity. Emerg Med J. 2017 Nov;34(11):703-710. doi: 10.1136/emermed-2016-206295. Epub 2017 Jul 27.
Moll HA Challenges in the validation of triage systems at emergency departments. J Clin Epidemiol. 2010 Apr;63(4):384-8. doi: 10.1016/j.jclinepi.2009.07.009. Epub 2009 Oct 28.
Mueller B, Kinoshita T, Peebles A, Graber MA, Lee S Artificial intelligence and machine learning in emergency medicine: a narrative review. Acute Med Surg. 2022 Mar 1;9(1):e740. doi: 10.1002/ams2.740. eCollection 2022 Jan-Dec.
Storm-Versloot MN, Ubbink DT, Kappelhof J, Luitse JS Comparison of an informally structured triage system, the emergency severity index, and the manchester triage system to distinguish patient priority in the emergency department. Acad Emerg Med. 2011 Aug;18(8):822-9. doi: 10.1111/j.1553-2712.2011.01122.x.
Evaluation of an Advanced Triage Tool for Gynecology and Obstetrics Emergencies Based on Artificial Intelligence Algorithms
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
